Military Press Releases
SEE OTHER BRANDS

The best the military industry news from the world

Military Press Releases: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Military Press Releases.

Press releases published on August 12, 2025

Kyverna Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

Kyverna Therapeutics Provides Business Update and Reports Second Quarter 2025 Financial Results

Topline data for registrational Phase 2 trial of KYV-101 in stiff person syndrome (SPS) and BLA submission anticipated in 1H 2026 Registrational Phase 3 KYV-101 trial in myasthenia gravis (MG) to include ~60 patients with enrollment to initiate by year-end …

Maze Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights

Maze Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights

MZE782 Phase 1 Trial in Healthy Volunteers to Provide Proof of Mechanism Data for Phenylketonuria (PKU) and Chronic Kidney Disease (CKD) Expected in Q3 2025 MZE829 Phase 2 HORIZON Trial Actively Enrolling Patients with APOL1-Mediated Kidney Disease; …

Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Journey Medical Corporation Reports Second Quarter 2025 Financial Results and Recent Corporate Highlights

Second quarter 2025 revenues were $15.0 million Emrosi™ net sales of $2.8 million generated in first full quarter on the market The Company joined the Russell 2000® and Russell 3000® Indexes in June 2025 Company to hold conference call today at 4:30 p.m. …

Erasca Reports Second Quarter 2025 Business Updates and Financial Results

Erasca Reports Second Quarter 2025 Business Updates and Financial Results

Efficient execution accelerated clinical entry of pan-RAS molecular glue ERAS-0015 and pan-KRAS inhibitor ERAS-4001 Phase 1 monotherapy data for RAS-targeting franchise expected in 2026 Robust balance sheet with cash, cash equivalents, and marketable …

Nkarta Reports Second Quarter 2025 Financial Results and Corporate Highlights

Nkarta Reports Second Quarter 2025 Financial Results and Corporate Highlights

Initial update for NKX019 in multiple autoimmune indications expected in second half of 2025 Cash balance of $334.0 million on June 30, 2025, including cash, cash equivalents and investments, expected to fund operations into 2029 SOUTH SAN FRANCISCO, Calif …

Editas Medicine Announces Second Quarter 2025 Results and Business Updates

Editas Medicine Announces Second Quarter 2025 Results and Business Updates

Company to select lead development candidate in September; on track to file IND by mid-2026 and achieve human proof-of-concept by year-end 2026 First IND/CTA accepted for CD19 HD Allo CAR T program as part of collaboration with Bristol Myers Squibb, …

Fate Therapeutics Reports Second Quarter 2025 Financial Results and Business Updates

Fate Therapeutics Reports Second Quarter 2025 Financial Results and Business Updates

First patient treated with FT819 off-the-shelf CAR T-cell product candidate following fludarabine-free conditioning for severe lupus nephritis demonstrated durability of response with drug-free definition of remission in systemic lupus erythematosus (DORIS …

Verrica Pharmaceuticals Reports Second Quarter 2025 Financial Results

Verrica Pharmaceuticals Reports Second Quarter 2025 Financial Results

–   Company reports $12.7 million in revenue in Q2’25, consisting primarily of $4.5 million in YCANTH® revenue, net, reflecting sequential growth of 32.5% over Q1’25 and $8.0 million in milestone revenue from Torii Pharmaceutical – – Completed Successful …

Spero Therapeutics Announces Second Quarter 2025 Operating Results and Provides a Business Update

Spero Therapeutics Announces Second Quarter 2025 Operating Results and Provides a Business Update

PIVOT-PO Phase 3 trial evaluating tebipenem Hbr in complicated urinary tract infection (cUTI) patients stopped early for efficacy following review by independent data monitoring committee (IDMC) Spero, along with its development partner, GSK, plans to …

374Water Reports Second Quarter 2025 Financial Results

374Water Reports Second Quarter 2025 Financial Results

Ongoing Deployments and Successful Waste Destruction Demonstrations Showcase AirSCWO Technology Across Municipal, Federal and Industrial Market Verticals DURHAM, N.C., Aug. 12, 2025 (GLOBE NEWSWIRE) -- 374Water Inc. (NASDAQ: SCWO) ("374Water" or the " …

Lyra Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

Lyra Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update

– Positive ENLIGHTEN 2 Phase 3 results announced in June 2025 propel business activities in manufacturing, regulatory strategy and ENLIGHTEN clinical dataset analysis to advance path forward for LYR-210 for treatment of chronic rhinosinusitis (CRS) – – …

Compass Therapeutics Announces Proposed Public Offering

Compass Therapeutics Announces Proposed Public Offering

BOSTON, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (“Compass”) (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today …

ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates

ProKidney Reports Second Quarter 2025 Financial Results and Provides Regulatory and Clinical Updates

FDA confirmed at a July 2025 Type B meeting and in the subsequent meeting minutes that eGFR slope is an acceptable surrogate endpoint for accelerated approval of rilparencel in patients with type 2 diabetes and advanced CKD; FDA also confirmed that the …

FormFactor, Inc. Announces CFO Transition

FormFactor, Inc. Announces CFO Transition

LIVERMORE, Calif., Aug. 12, 2025 (GLOBE NEWSWIRE) -- FormFactor, Inc. (Nasdaq: FORM) (the “Company” or “FormFactor”) today announced that Aric McKinnis, currently its Vice President and Corporate Controller, has been appointed to serve as the Company’s new …

Pathway Health Recognized as a 2025 Minnesota Star Tribune National Standard Top Workplace for the Third Consecutive Year

Pathway Health Recognized as a 2025 Minnesota Star Tribune National Standard Top Workplace for the Third Consecutive Year

LAKE ELMO, Minn., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Pathway Health, a leading provider of health care consulting services, interim and permanent leadership, technology implementation, and training solutions, has been recognized as a 2025 Minnesota Star …

Cognition Therapeutics Receives End-of-Phase 2 Meeting Minutes Confirming Alignment with U.S. FDA on Registrational Path for Zervimesine (CT1812) in Alzheimer’s Disease

Cognition Therapeutics Receives End-of-Phase 2 Meeting Minutes Confirming Alignment with U.S. FDA on Registrational Path for Zervimesine (CT1812) in Alzheimer’s Disease

- Cognition and FDA align on enriched population, study design, and endpoints - PURCHASE, N.Y., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat …

Spectral Medical and Vantive Announce Topline Results from Spectral’s Tigris Trial Evaluating PMX Hemoadsorption Therapy for Endotoxic Septic Shock

Spectral Medical and Vantive Announce Topline Results from Spectral’s Tigris Trial Evaluating PMX Hemoadsorption Therapy for Endotoxic Septic Shock

Results exceed prespecified primary endpoint of 95% posterior probability of benefit for PMX on 28-day mortality Pooled absolute risk reduction of 8.3%; Relative risk reduction of 18% Key secondary endpoint: 90-day Mortality 17.4% lower with PMX and >99% …

Spectral AI Announces 2025 Second Quarter Financial Results

Spectral AI Announces 2025 Second Quarter Financial Results

Q2 Overview Research …

Pest Control Expert Brittany Thacker Explains Fall Bug Surges in HelloNation Magazine

Pest Control Expert Brittany Thacker Explains Fall Bug Surges in HelloNation Magazine

JASPER, Ga., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Why do bugs seem to flood into homes during the fall months? According to Brittany Thacker of Daniel …

Landscape Expert Jess Aragon of Timberrock Landscape Center Explains What to Do Before You Start a DIY Yard Project in HelloNation Magazine

Landscape Expert Jess Aragon of Timberrock Landscape Center Explains What to Do Before You Start a DIY Yard Project in HelloNation Magazine

WINDSOR, Colo., Aug. 12, 2025 (GLOBE NEWSWIRE) -- What should I do before starting a DIY yard project? Homeowners who ask this question often hope to improve their outdoor spaces with their own effort, but may not know where to begin. According to …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions